Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | December 14, 2022 09:06am

Gainers

  • Vallon Pharmaceuticals (NASDAQ:VLON) shares increased by 232.7% to $0.84 during Wednesday's pre-market session. The market value of their outstanding shares is at $10.6 million.
  • Immix Biopharma (NASDAQ:IMMX) stock moved upwards by 45.2% to $2.12. The market value of their outstanding shares is at $29.5 million.
  • Avidity Biosciences (NASDAQ:RNA) stock increased by 34.79% to $14.8. The company's market cap stands at $806.0 million.
  • Kymera Therapeutics (NASDAQ:KYMR) shares moved upwards by 32.95% to $34.37. The market value of their outstanding shares is at $1.8 billion.
  • Fortress Biotech (NASDAQ:FBIO) stock moved upwards by 23.34% to $0.81. The market value of their outstanding shares is at $87.9 million.
  • Passage Bio (NASDAQ:PASG) shares moved upwards by 16.32% to $1.33. The company's market cap stands at $72.3 million.

Losers

  • Yumanity Therapeutics (NASDAQ:YMTX) stock decreased by 18.7% to $1.65 during Wednesday's pre-market session. The market value of their outstanding shares is at $17.9 million.
  • NeuroOne Medical Tech (NASDAQ:NMTC) stock fell 18.56% to $1.8. The market value of their outstanding shares is at $29.1 million. As per the press release, Q4 earnings came out yesterday.
  • BeyondSpring (NASDAQ:BYSI) stock fell 17.48% to $0.85. The market value of their outstanding shares is at $33.0 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares fell 12.65% to $0.21. The market value of their outstanding shares is at $8.7 million.
  • Vincerx Pharma (NASDAQ:VINC) stock decreased by 10.44% to $0.97. The market value of their outstanding shares is at $20.4 million.
  • OpGen (NASDAQ:OPGN) shares fell 9.53% to $0.21. The market value of their outstanding shares is at $11.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BYSI FBIO HCTI IMMX KYMR NMTC OPGN PASG RNA VINC VLON YMTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist